L'estratto di Andrographis è efficace contro il COVID-19?

Andrographis extract is a strong products of Xi an Sost Biotech Co,. Ltd. Called fah talai jone in Thai and "the king of bitters," among other names, andrographis is a small annual plant. In India's traditional medical system of Ayurveda, the plant's dried leaves and shoots are used for bronchitis, cough, diarrhea, dyspepsia, fever, inflammation, and skin diseases. In traditional Chinese medicine, the plant has been used to treat colitis, cough, dysentery, fever, influenza, and sore throat. Modern studies have focused on andrographis' potential benefits for respiratory and digestive conditions. However, that's not all it does. 

Until the  end of  2019, COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus 2 has posed an enormous threat to public health worldwide. Andrographidine C (MOL008223) and andrographolide (MOL008232) were found with strong binding affinity to the target active sites of the potential targets by molecular docking.This research identified novel molecules against COVID-19 for developing natural medicines from Andrographis paniculate. A research report first published on 11th November 2021 by Royal Society Chemistry says that an andrographolide sulfonates preparation, named Xiyanping injection in Chinese, which was prepared from the aqueous extract of Andrographis paniculata, showed favorable therapeutic effectiveness on COVID-19, suggesting Andrographis paniculata could contain powerful therapeutic ingredients against COVID-19.

Alla fine di agosto 2020, The Nation Thailand ha riferito che la dose più bassa di andrographis ha mostrato benefici nello studio preliminare, soprattutto per la tosse. Entro tre giorni, sia il volume della tosse che la gravità generale dei sintomi sono diminuiti in modo significativo. Dopo cinque giorni, altri sintomi sono migliorati e i test di-reazione a catena della polimerasi (PCR) in tempo reale sono risultati negativi per il virus COVID-19 in due pazienti. Dopo tre settimane, i test PCR in tempo reale sono risultati negativi in ​​tutti e sei i soggetti. Alla fine di dicembre 2020, il governo della Thailandia ha approvato uno studio pilota sull'uso dell'erba andrographis dell'Asia meridionale per trattare i primi sintomi e ridurre la gravità del COVID-19.

Xi an Sost Biotech Co., Ltd. integra la ricerca e lo sviluppo, la produzione e le vendite per molti anni. Siamo il tuo affidabileandrographis extract wholesaler.

 

� Need me? Click here to send an inqury.

※ We can supply customized service as your request.

---

 Tel: 0086-131-6572-3252

 Email: info@sostherbusa.com

 Skype: Gloriaheng94@gmail.com